Updates are available Correction dated 2021-11-30
Click to view Correction: https://doi.org/10.1038/s41398-021-01731-x
-
Authors
Allen, Paul
Hird, Emily J. https://orcid.org/0000-0001-6599-7292
Orlov, Natasza
Modinos, Gemma https://orcid.org/0000-0002-7870-066X
Bossong, Matthijs
Antoniades, Mathilde
Sampson, Carly
Azis, Matilda
Howes, Oliver
Stone, James
Perez, Jesus
Broome, Matthew
Grace, Anthony A.
McGuire, Philip
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MC_PC_17214)
Wellcome Trust (#202397/Z/16/Z)
Royal Society (#202397/Z/16/Z)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Veni Fellowship)
- License Information
-
More Information
Article History
Received: 25 March 2021
Accepted: 26 October 2021
First Online: 10 November 2021
Change Date: 30 November 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41398-021-01731-x
COMPETING INTERESTS
: A.G. receives research funding from Alkermes, Lundbeck, and receives consulting fees from Takeda, Roche, Lyra, and Concert. ODH has received investigator-initiated research funding from and/ or participated in advisory/speaker meetings organised by Astra-Zeneca, Autifony, BMS, Eli Lilly, Heptares, Jansenn, Lundbeck, Lyden-Delta, Otsuka, Servier, Sunovion, Rand and Roche. Neither ODH or his family have been employed by or have holdings/a financial stake in any biomedical company.
